Catherine Hall, VP Product Strategy at endpoint Clinical tells the story of the past of Direct-to-Patient (DTP) logistics and speculates on the future of DTP, and Virtual, Decentralized, and Hybrid clinical trials.
Digital Biomarkers Solution shows pathway to reduced clinical trial sample sizes, shorter durations
April 5th 2024Digital biomarkers provide a pathway to the future where clinical trial sponsors can potentially benefit from reduced trial duration and sample size. Learn more about these benefits from a simulated study.